Ardena | News & Insights

News
15.06.2021

Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.

Read more

News
18.05.2021

Press Release | Investment in Flow Cytometry unlocks the secrets of single cells

Read more
Press Release | New cancer immunotherapy treatment enters clinical phase featured image

News
27.04.2021

Press Release | New cancer immunotherapy treatment enters clinical phase

Read more
Launch new Ardena career page featured image

Insights
30.03.2021

Launch new Ardena career page

Read more
Patrick Walleser, new Ardena Account Management Director DACH region featured image

Insights
23.02.2021

Patrick Walleser, new Ardena Account Management Director DACH region

Read more

News
24.11.2020

Commercial Agency Agreement Taiwan (ROC)

Read more
CVC Credit Partners refinances Ardena’s credit facilities featured image

News
13.07.2020

CVC Credit Partners refinances Ardena’s credit facilities

Read more
EMA and FDA have activated plans to fast track the development and approval of therapeutics against COVID-19. featured image

Insights
03.04.2020

EMA and FDA have activated plans to fast track the development and approval of therapeutics against COVID-19.

Read more
EMA extends nitrosamine risk assessments to investigational drugs featured image

Insights
02.04.2020

EMA extends nitrosamine risk assessments to investigational drugs

Read more
Ardena Assen is doubling its capacity – Update 25.03.2020 featured image

News
25.03.2020

Ardena Assen is doubling its capacity – Update 25.03.2020

Read more